Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Heart Failure and Atrial Fibrillation, Like Fire and Fury
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Dilated cardiomyopathy: so many cardiomyopathies!
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE
Primary Prevention of Heart Failure in Women